Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $24.40. The company's market cap stands at 138.7B, with a P/E ratio of 14.48 and a dividend yield of 6.9%.
On 2025-11-07, Pfizer(PFE) stock moved within a range of $24.28 to $24.63. With shares now at $24.40, the stock is trading +0.5% above its intraday low and -1.0% below the session's peak.
Trading activity shows a volume of 9.1M, compared to an average daily volume of 100.66M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
PFE News
Home Investing No Brainer Dividend Stocks To Buy Now Investing No Brainer Dividend Stocks To Buy Now By Vandita Jadeja Nov 6, 2025 11:36 am This post may con...
The Delaware Chancery Court denied Pfizer Inc.’s (NYSE:PFE) request for a temporary restraining order to prevent Metsera, Inc. (NASDAQ:MTSR) from terminating th...
Novo Nordisk (NVO) has again increased its offer for weight-loss drug start-up Metsera (MTSR) in an effort to beat out a sweetened offer from Pfizer (PFE), Drew...
Analyst ratings
58%
of 24 ratingsMore PFE News
The battle between Pfizer (PFE) and Novo Nordisk (NVO) is "getting ugly," an analyst said Thursday as Metsera (MTSR) stock surged on reports that Pfizer has mat...
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...
Key Points Pfizer's Q3 earnings fell, but the company still raised its full-year earnings guidance. Major cost reductions remain on track, which should signif...
Are you looking for more income from your portfolio? Even with bond yields still near multiyear highs, plenty of dividend stocks are worth considering. Not only...
(RTTNews) - Metsera Inc. (MTSR) released a statement after the Delaware Court of Chancery rejected Pfizer Inc.'s (PFE) request for a temporary restraining order...
Pfizer (PFE) has matched Novo Nordisk’s (NVO) offer to buy weight-loss drug start-up Metsera (MTSR) for up to $10B, Financial Times’ Oliver Barnes, James Fontan...
Pfizer (PFE) issued the following statement in response to the Delaware Chancery Court’s decision denying Pfizer’s request for a temporary restraining order to...